The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug approved in decades and the first in a new class of medications. British ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

and Staphylococcus saprophyticus. Globally, 150 million people are affected by UTI worldwide.” Usually, UTI can occur to ...

One in four women are affected by a UTI in their lifetime, and approximately 30 percent ... and a type of staph infection known as Staphylococcus saprophyticus. “The approval of Blujepa is a crucial ...

saprophyticus and Acinetobacter species do not and therefore give false-negative results. In a patient with a high index of suspicion of UTI and a negative dipstick, direct examination of the ...

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract infections (uUTIs) in women and young girls, in a first approval of its ...

One in four women are affected by a UTI in their lifetime ... and a type of staph infection known as Staphylococcus saprophyticus. “The approval of Blujepa is a crucial milestone with uUTIs ...

A UTI is considered uncomplicated if it occurs ... coli, klebsiella, Citrobacter freundii, Staphylococcus saprophyticus and Enterococcus faecalis. The most common side effects reported from ...